GlassScriptPhysician profile
Carmen D Herring
NPI 1700236908
$1,426.58
in general payments reported to CMS, 2019-2025
18 companies · $893 in 2025
The $893 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.12 · 2022: $12.92 · 2024: $502 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $583.88 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $157.45 | 2024-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $145.03 | 2025 | Adstiladrin |
| Tolmar, INC. | $95.97 | 2024-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $81.88 | 2024-2025 | Rezum Generator, Axonics |
| Astellas Pharma US INC | $66.22 | 2025 | Xtandi |
| Verity Pharmaceuticals INC. | $41.53 | 2024 | Trelstar |
| Bayer Healthcare Pharmaceuticals INC. | $40.08 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $38.03 | 2024 | Prolaris |
| Genentech USA, INC. | $32.04 | 2021-2022 | |
| Calyxo, INC. | $21.96 | 2024 | Cvac Aspiration System |
| Endo USA, INC. | $21.67 | 2025 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $20.64 | 2024 | Airsupra |
| Immunitybio, INC. | $20.05 | 2024 | |
| Cycle Pharmaceuticals INC | $16.13 | 2024 | Tiopronin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $15.45 | 2025 | |
| Olympus America INC. | $14.40 | 2024 | Bovie |
| Laborie Medical Technologies Corp. | $14.17 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Herring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.